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Does a low-salt diet reduce morbidity 
and mortality in congestive heart failure?
EVIDENCE-BASED ANSWER No randomized con-
trolled trials (RCTs) have addressed the independent
role of sodium restriction in the morbidity or mortal-
ity of congestive heart failure. However, current
guidelines recommend sodium restriction for sec-
ondary prevention of congestive heart failure exac-
erbation. (Grade of recommendation: D.) Clinical tri-
als of multifactorial, nondrug interventions have
shown an association of sodium restriction with
reduced morbidity and improved quality of life in
some populations with congestive heart failure.
(Grade of recommendation: C.)
EVIDENCE SUMMARY Sodium restriction is a
mainstay of nonpharmacologic therapy for conges-
tive heart failure, although no evidence proves that
sodium restriction alone reduces morbidity and mor-
tality.1 Sodium restriction reduces hypertension2,3 and
left ventricular hypertrophy,4 both risk factors for
congestive heart failure.
Studies of multifactorial interventions correlate
reduced congestive heart failure morbidity with sodi-
um restriction or dietary counseling. These results
cannot be generalized to sodium restriction indepen-
dent of the other nondrug interventions. A small RCT
compared a program of exercise, cognitive thera-
py/stress management, salt restriction, and weight
reduction to treating congestive heart failure with
digoxin or placebo.5 The nondrug interventions
improved functional capacity, body weight, and
mood but not ejection fraction in patients with con-
gestive heart failure.5 A systematic review of 6 RCTs
showed that multidisciplinary heart failure disease
management programs, which emphasized dietary
counseling and/or sodium intake reduction,
improved functional capacity, patient satisfaction,
and quality of life.6
A large RCT that investigated how sodium reduc-
tion affects hypertension and frequency of cardio-
vascular events (including congestive heart failure)
in the elderly did not show a significant difference
in primary prevention of cardiovascular events
between the sodium-restricted group and controls.3,7
Two prospective cohort studies linked high sodium
intake to cardiovascular mortality and all-cause mor-
tality in overweight persons independent of other
cardiovascular risk factors.8,9
RECOMMENDATIONS FROM OTHERS Physiological
principles, observational studies, common practice,
and expert opinion support sodium restriction for
reducing edema and the need for diuretic agents in
patients with congestive heart failure.1 No clinical
trial evidence favors a 2-g over a 3- to 4-g sodium
restriction. See Table for common recommendations.
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TA B L E  
Recommended sodium restrictions
Patient populations 
with congestive heart failure Sodium restriction
Older adult1 1.6 g Na
With fluid retention Moderate sodium 
or hypertension11 reduction
At risk for or with Prudent dietary salt 
asymptomatic heart failure11 reduction
Older adult nursing Low salt
home residents12
Taking diuretics10 2 g Na
